Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas: a progress report.
In an Easter Cooperative Oncology Group trial, Cytoxan-prednisone (CP) Induction was compared to BCNU-prednisone (BP) in 273 patients with lymphocytic lymphoma. Response rates were comparable, with 21% achieving complete response and 40%, partial response. Patients with a nodular pattern responded better. Maintenance phase comparing cyclic intensive therapy (BCVP) with intermittent chlorambucil revealed the superiority of BCVP as demonstrated by improvement of the quality of response and somewhat longer remissions. The value of the Rappaport classification in the evaluation of lymphoma chemotherapy results is discussed. It is suggested tha NHL be separated into "favorable" and "unfavorable" groups, based on the presence or absence of nodularity and treatment schedules devised accordingly.
D000328:Adult; D000368:Aged; D002699:Chlorambucil / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004338:Drug Combinations; D005038:Ethylnitrosourea / Q000008:administration & dosage* / Q000031:analogs & derivatives; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000008:administration & dosage*; D011241:Prednisone / Q000008:administration & dosage*; D012075:Remission, Spontaneous; D013997:Time Factors
D004338:Drug Combinations; D009607:Nitrosourea Compounds; D002699:Chlorambucil; D003520:Cyclophosphamide; D005038:Ethylnitrosourea; D011241:Prednisone